Cross Cancer Institute ( Site 0033)

Edmonton, Alberta T6G 1Z2

1 studies enrolling now · 2 studies all time

What they study most

Advanced Solid Tumors, Gastric Cancer, Gastroesophageal Junction Cancer

Studies at this site

• A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001) — Recruiting now
• Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585) — Completed